Molecular Pathology of Thymic Epithelial Neoplasms
Section snippets
Clinico-Pathologic Features of Thymic Tumors
Thymoma classification has been a challenging field in pathology because of the wide heterogeneity of these tumors from the viewpoint of pathology, clinical characteristics, and prognosis. The so-called “histogenic” classification, which tried to reflect the major functional and anatomic compartments of the thymus, distinguished medullary, mixed, predominantly cortical and cortical thymomas, and well-differentiated thymic carcinoma [10], [11], [12], [13]. In 1999, the World Health Organization
Molecular Pathogenesis of Thymic Tumors
Currently, there is widespread acceptance that the neoplastic transformation of normal epithelial cells represents a multistep accumulation of genetic and epigenetic alterations, including abnormalities for the activation of oncogenes and inactivation of tumor suppressor genes (TSG). While oncogenes and TSGs are required for normal cell proliferation and differentiation, their aberrant expression leads to abnormal cell proliferation and tumor development. Oncogenes have a role in signal
Molecular Profiling Studies in Thymic Epithelial Tumors
There is a belief that the pathogenesis and behavior of individual thymic tumors cannot be completely understood through the analysis of individual or a small number of genes. Recently, the use of molecular global profiling technologies, including DNA, cDNA microarrays, and proteomics-based analyses, has led to a significant number of exciting new biologic discoveries and important correlations between gene and protein expression patterns and disease states in several human cancers. In thymic
Summary
Although the etiology of thymic epithelial tumors is unknown, during the last two decades there has been progress in elucidating some genetic abnormalities present and molecular pathways altered in these tumors (Table 1). These abnormalities, while bearing distinctions and similiarities to those described in other tumors, can be organized under the “hallmarks of cancer,” as proposed by Hanahan and Weinberg [17] (Fig. 1). However, this progress is still meager and has not led to better tumor
References (62)
- et al.
Chromosome 6 suffers frequent and multiple aberrations in thymoma
Am J Pathol
(2002) - et al.
Recurrent genetic aberrations in thymoma and thymic carcinoma
Am J Pathol
(2000) - et al.
Thymic epithelial tumors can develop along two different pathogenetic pathways
Am J Pathol
(2001) - et al.
Thymoma: a clinicopathologic study
J Thorac Cardiovasc Surg
(1961) - et al.
The hallmarks of cancer
Cell
(2000) - et al.
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas
Cancer Lett
(2007) - et al.
Immunohistochemical KIT (CD117) expression in thymic epithelial tumors
Chest
(2005) - et al.
Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness
Hum Pathol
(1996) - et al.
Progress in understanding the molecular pathogenesis of human lung cancer
Biochim Biophys Acta
(1998) - et al.
Focus on lung cancer
Cancer Cell
(2002)